AstraZeneca at FoG London 2027

Jan 27–28, 2027 London, UK ~8.3k attendees Website

AstraZeneca takes part in 2 sessions at FoG London 2027 in London. Its sessions cover how to pick a sequencing technology and how the human role shifts from being in the loop to being on the loop. The sequencing topic weighs short reads against long reads and newer approaches.

OrganizationFoG London 2027 Attendance
AstraZeneca
Cambridge, UK
Large pharma
Global biopharmaceutical company with medicines in oncology, rare disease, cardiovascular, renal, respiratory and immunology.
Panel
Wed Jan 27
17:30–18:00
Choosing the Right Sequencing Technology: Short Reads, Long Reads & Beyond
How researchers weigh short-read and long-read sequencing on accuracy, resolution, throughput and cost, and when to combine them.
with Relation Therapeutics, Wellcome Sanger Institute
Talk
Wed Jan 27
17:30–18:00
From Human IN the Loop to Human ON the Loop
Why scientists should help build AI tools from the start, and why keeping them reliable needs ongoing scientific oversight.
Also
Presenting at the meeting, beyond the sessions above

Explore the full FoG London 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in London. Leave your work email and we’ll be in touch.

Privacy

Download the full FoG London 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at AstraZeneca

Tell us what you sell and we’ll find the people at AstraZeneca most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Front Line Genomics or the Festival of Genomics. Submit a correction